A substantial proportion of the increased cardiovascular risk in patients with OA can be attributed to these commonly used drugs.
New classification criteria for spondyloarthritis cover a wide spectrum of patients.
Men are more likely to stay the course of TNF inhibitor therapy.
Early, intensive treatment of RA has long-term benefits, including a reduction in mortality, report Dutch researchers at EULAR 2018.
A bio-psychosocial approach geared to the patient’s specific needs, preferences, priorities, and pain characteristics.
Urinary markers may predict the development of osteolysis following total hip replacement.
Insights from digital patient communities on disease-related impairments that PRO tools may miss.
Real-world health claims data demonstrate an elevated risk of cardiovascular and autoimmune diseases.
Updates from the 2018 British Society for Rheumatology conference focus on RA treatment targets and resistance to biologics.
Smoking, obesity, RF and anti-CCP positivity, high disease activity, early erosions—one of these was found to protect against severe joint damage.